Don Stader, MD FACEP FASAM is a board-certified emergency and addiction medicine physician, who works at Swedish Medical Center and Lincoln Health in Colorado. Don is also the founder and Executive Director of The Naloxone Project. He is the founder and past chair of Colorado ACEP's Opioid Task Force, the Editor-in-Chief of COACEP's 2017 Opioid Prescribing & Treatment Guidelines and the CO's CURE’s guidelines on pain control and opioid stewardship. Don served for over 2 years as the Senior Pain Management & Opioid Policy Physician Adviser for the Colorado Hospital Association and serves on multiple national and local committees addressing the opioid epidemic in Colorado and across the nation, he is the current chair of ACEP’s Pain & Addiction Management Section. He is the Medical Director of the Compass Opioid Stewardship Program, a nationwide initiative to improve pain control, prescribing habits, addiction treatment and opioid stewardship for primary care clinicians.

Rachael Duncan, PharmD BCPS BCCCP Rachael is a pharmacist and consultant for Stader Opioid Consultants based in Colorado. She has spent the past eight years focused on policy, advocacy, and educational work surrounding harm reduction and substance use disorder treatment at both the state and national level. She serves on the board of directors for the nonprofit The Naloxone Project and is Co-Chair of the MOMs (Maternal Overdose Matters) Initiative, which helps birthing hospitals distribute naloxone directly to at-risk perinatal patients and families. She is also program director for MOMs+, which helps birthing hospitals provide equitable access to treatment and recovery for perinatal patients affected by substance use disorder. Her clinical practice is in hospital-based pharmacy.

Joshua Blum, MD is a board-certified internist and addiction medicine physician who practiced at Denver Health and Hospital Authority in Denver, CO as the director of outpatient substance use disorder treatment.  As an institutional quality officer, he led initiatives on pain and opioid management and chaired Denver Health’s pharmacy and therapeutics committee. He is a past president of the Colorado chapter of the American Society of Addiction Medicine, and co-chair of the Provider Education Workgroup at the Colorado Consortium for Prescription Drug Abuse Prevention.  He also serves on the boards of the Colorado Pain Society and the Harm Reduction Action Center. Dr. Blum attended Dartmouth College and the University of Southern California School of Medicine before completing his medicine residency at the University of Colorado.